Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 53 (3) , 401-406
- https://doi.org/10.1016/s0015-0282(16)53330-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- New Therapy for EndometriosisNew England Journal of Medicine, 1988
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.BMJ, 1987
- Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patientsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1986
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.Journal of Clinical Endocrinology & Metabolism, 1982
- ENDOMETRIOSIS AND INFERTILITYClinical Obstetrics and Gynecology, 1979
- Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing HormoneScience, 1978
- Estimation of confidence limits for the cumulative probability of survival in life table analysisJournal of Chronic Diseases, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958